These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15117867)

  • 1. Sildenafil use in patients with the Eisenmenger syndrome.
    Rosenthal E
    Circulation; 2004 Apr; 109(16):e197; author reply e197. PubMed ID: 15117867
    [No Abstract]   [Full Text] [Related]  

  • 2. Eisenmenger's syndrome in a 27 week pregnancy--management with bosentan and sildenafil.
    Molelekwa V; Akhter P; McKenna P; Bowen M; Walsh K
    Ir Med J; 2005 Mar; 98(3):87-8. PubMed ID: 15869069
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sildenafil in pulmonary hypertension: the opinion of pediatric cardiologist].
    Micheletti A; Butera G; Chessa M; Carminati M
    Pediatr Med Chir; 2008; 30(3):159-62. PubMed ID: 19024861
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of sildenafil on survival of patients with Eisenmenger syndrome.
    Sun YJ; Yang T; Zeng WJ; Gu Q; Ni XH; Zhao ZH; Liu ZH; Xiong CM; He JG
    J Clin Pharmacol; 2013 Jun; 53(6):611-8. PubMed ID: 23553708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil in Eisenmenger syndrome: safety first.
    Wort SJ
    Int J Cardiol; 2007 Sep; 120(3):314-6. PubMed ID: 17477991
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension.
    Chau EM; Fan KY; Chow WH
    Int J Cardiol; 2007 Sep; 120(3):301-5. PubMed ID: 17174418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyspnea in Eisenmenger syndrome and its amelioration by sildenafil: role of J receptors.
    Anand A; Srivastava N; Barwad P; Ramakrishnan S; Roy A; Bhargava B
    Int J Cardiol; 2014 Jul; 174(3):574-8. PubMed ID: 24820738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bosenten and sildenafil in the treatment of Eisenmenger syndrome].
    Białkowski J
    Kardiol Pol; 2010 Feb; 68(2):248-9. PubMed ID: 20301040
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of Eisenmenger syndrome in pregnancy with sildenafil and L-arginine.
    Lacassie HJ; Germain AM; Valdés G; Fernández MS; Allamand F; López H
    Obstet Gynecol; 2004 May; 103(5 Pt 2):1118-20. PubMed ID: 15121629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sildenafil citrate on five dogs with Eisenmenger's syndrome.
    Nakamura K; Yamasaki M; Ohta H; Sasaki N; Murakami M; Bandula Kumara WR; Takiguchi M
    J Small Anim Pract; 2011 Nov; 52(11):595-8. PubMed ID: 21985577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
    Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of long-term combined therapy with inhaled iloprost and oral sildenafil in an adult patient with eisenmenger syndrome.
    Okyay K; Cemri M; Boyac B; Yalcn R; Cengel A
    Cardiol Rev; 2005; 13(6):312-4. PubMed ID: 16230890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiple combined treatment in an adult patient with Eisenmenger's syndrome.
    Grutter G; Guccione P; Mantione L; Giannico S; Parisi F; Di Donato R; Pongiglione G
    Int J Cardiol; 2011 Sep; 151(3):372-3. PubMed ID: 21757244
    [No Abstract]   [Full Text] [Related]  

  • 14. [Safety of Sildenafil in men with cardiovascular diseases].
    Chen GQ; Bai WJ
    Zhonghua Nan Ke Xue; 2005 Mar; 11(3):223-5. PubMed ID: 15804120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.
    Gordeuk VR
    Haematologica; 2005 Apr; 90(4):433-4. PubMed ID: 15820926
    [No Abstract]   [Full Text] [Related]  

  • 16. Sildenafil for the treatment of Raynaud's phenomenon.
    Heymann WR
    J Am Acad Dermatol; 2006 Sep; 55(3):501-2. PubMed ID: 16908357
    [No Abstract]   [Full Text] [Related]  

  • 17. More potential for sildenafil than potency.
    Mahler F; Baumgartner I
    Circulation; 2005 Nov; 112(19):2894-5. PubMed ID: 16275879
    [No Abstract]   [Full Text] [Related]  

  • 18. [New indications for sildenafil in sight. Potency drug is potent in pulmonary hypertension].
    MMW Fortschr Med; 2004 Apr; 146(18):8. PubMed ID: 15366459
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of sildenafil citrate in Raynaud's phenomenon: comment on the article by Thompson et al.
    Lichtenstein JR
    Arthritis Rheum; 2003 Jan; 48(1):282-3; author reply 283. PubMed ID: 12528146
    [No Abstract]   [Full Text] [Related]  

  • 20. Sildenafil for pulmonary arterial hypertension complicating respiratory disease.
    Aggarwal AN
    Indian J Chest Dis Allied Sci; 2008; 50(4):317-9. PubMed ID: 19035049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.